Skip to product information
1 of 1

Rat Anti-Mouse CD86/B702 Antibody (S-R434)

Rat Anti-Mouse CD86/B702 Antibody (S-R434)

Catalog Number: S0B0827 Application: FCM Reactivity: Mouse Conjugation: Unconjugated Brand: Starter
Price:
Regular price $59.00 SGD
Regular price Sale price $59.00 SGD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rat
Antigen CD86/B7-2
Synonyms T-lymphocyte activation antigen CD86, Activation B7-2 antigen, B70, BU63, CTLA-4 counter-receptor B7.2, FUN-1
Location Cell membrane
Accession P42081
Clone Number S-R434
Antibody Type Mouse mAb
Isotype IgG2a,k
Application FCM
Reactivity Ms
Purification Protein G
Concentration 2 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
FCM 1:2000

Background

CD86, also known as B7-2, is a crucial protein molecule in the immune system, belonging to the B7 protein family. This family comprises various costimulatory molecules that are essential for T-cell activation, proliferation, and the exertion of effector functions. CD86 provides the second signal (costimulatory signal) for T-cell activation by binding to the CD28 receptor on T-cells. This signal is necessary for the full activation and differentiation of T-cells into effector T-cells (e.g., Th1, Th2) or memory T-cells. CD86 also exerts a negative regulatory role through its interaction with the CTLA-4 receptor on T-cells. CTLA-4 has a higher affinity for CD86 than CD28, allowing it to competitively bind to CD86 during the later stages of T-cell activation, thereby inhibiting further T-cell activation and preventing excessive immune responses. CD86 also exerts a negative regulatory role through its interaction with the CTLA-4 receptor on T-cells. CTLA-4 has a higher affinity for CD86 than CD28, allowing it to competitively bind to CD86 during the later stages of T-cell activation, thereby inhibiting further T-cell activation and preventing excessive immune responses.

Picture

FC

Flow cytometric analysis of C57BL/6 mouse splenocytes treated with 500ng/ml LPS for 3 days, labelling CD86/B7-2 antibody at 1/2000 (0.1 μg) dilution (Right) compared with a Mouse monoclonal IgG isotype control (Left). Then cells were stained with CD19 - PE/Cy7 separately. Goat Anti - Mouse IgG Alexa Fluor® 647 was used as the secondary antibody. Gated on total viable cells.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)